We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+11.11%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$218B
AUM Growth
-$5.41B
Cap. Flow
-$25.1B
Cap. Flow %
-11.51%
Top 10 Hldgs %
47.1%
Holding
5,603
New
345
Increased
2,379
Reduced
1,667
Closed
541

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.82B
2
AAPL icon
Apple
AAPL
+$1.62B
3
UNH icon
UnitedHealth
UNH
+$1.03B
4
XOM icon
ExxonMobil
XOM
+$869M
5
TSLA icon
Tesla
TSLA
+$701M

Sector Composition

Rank Sector Weight
1 Technology 12.19%
2 Consumer Discretionary 5.03%
3 Healthcare 4.78%
4 Financials 4.74%
5 Communication Services 2.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLSE icon
4751
Pulse Biosciences
PLSE
$2.45B
$635 ﹤0.01%
189
-12
-6% -$36
PSEC icon
4752
Prospect Capital
PSEC
$1.07B
$619 ﹤0.01%
89
PHG icon
4753
Philips
PHG
$25.6B
$606 ﹤0.01%
39
ZVRA icon
4754
Zevra Therapeutics
ZVRA
$569M
$600 ﹤0.01%
109
-244
-69% -$1.29K
BOC icon
4755
Boston Omaha
BOC
$429M
$568 ﹤0.01%
+24
New +$597
JETS icon
4756
US Global Jets ETF
JETS
$778M
$559 ﹤0.01%
30
-600
-95% -$11.6K
ERY icon
4757
Direxion Daily Energy Bear 2X ETF
ERY
$39.7M
$553 ﹤0.01%
18
NPCE icon
4758
Neuropace
NPCE
$439M
$548 ﹤0.01%
118
USL icon
4759
United States 12 Month Oil Fund,
USL
$44.9M
$540 ﹤0.01%
16
AUDC icon
4760
AudioCodes
AUDC
$245M
$513 ﹤0.01%
34
-6
-15% -$102
BPT
4761
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$512 ﹤0.01%
67
CRF
4762
Cornerstone Total Return Fund
CRF
$1.16B
$487 ﹤0.01%
77
SMMF
4763
DELISTED
Summit Financial Group, Inc.
SMMF
$477 ﹤0.01%
+23
New +$560
NBST
4764
DELISTED
Newbury Street Acquisition Corporation Common Stock
NBST
$431 ﹤0.01%
42
ITB icon
4765
iShares US Home Construction ETF
ITB
$2.27B
$422 ﹤0.01%
6
EACPW
4766
DELISTED
Edify Acquisition Corp. Warrant
EACPW
$421 ﹤0.01%
14,000
SGHC icon
4767
SGHC Ltd
SGHC
$7.14B
$383 ﹤0.01%
95
-5
-5% -$18
SOAR icon
4768
Volato Group
SOAR
$7.48M
$375 ﹤0.01%
1
VHC icon
4769
VirnetX Holding Corp
VHC
$54.6M
$373 ﹤0.01%
14
-5
-26% -$162
DMTK
4770
DELISTED
DermTech, Inc. Common Stock
DMTK
$357 ﹤0.01%
97
SSYS icon
4771
Stratasys
SSYS
$688M
$330 ﹤0.01%
20
-9,640
-100% -$136K
EWD icon
4772
iShares MSCI Sweden ETF
EWD
$547M
$320 ﹤0.01%
9
DRN icon
4773
Direxion Daily Real Estate Bull 3X ETF
DRN
$45.7M
$315 ﹤0.01%
33
FTHM icon
4774
Fathom Holdings
FTHM
$26.8M
$306 ﹤0.01%
72
LVRO
4775
DELISTED
Lavoro
LVRO
$306 ﹤0.01%
+53
New +$378

Similar funds

Barclays's Q1 2023 Portfolio in Review

As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.

  • Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
  • Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
  • Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
  • Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
  • Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
  • Barclays opened 345 new positions and closed 541 in Q1 2023.
  • Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.

Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.